Nektar Therapeutics Debt Instrument, Interest Rate, Stated Percentage
Nektar Therapeutics (NKTR) had Debt Instrument, Interest Rate, Stated Percentage of 12.00% as of 2014-03-31, per its 10-Q filed 2014-05-08.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateStatedPercentage · last filed 2014-05-08
- 2014-03-31: Debt Instrument, Interest Rate, Stated Percentage 12.00%.
- 2013-12-31: Debt Instrument, Interest Rate, Stated Percentage 12.00%.
- 2013-09-30: Debt Instrument, Interest Rate, Stated Percentage 12.00%.
- 2013-06-30: Debt Instrument, Interest Rate, Stated Percentage 12.00%.
| Period end | Debt Instrument, Interest Rate, Stated Percentage |
|---|---|
| 2014-03-31 | 12.00% 10-Q · filed 2014-05-08 |
| 2013-12-31 | 12.00% 10-K · filed 2014-02-27 |
| 2013-09-30 | 12.00% 10-Q · filed 2013-11-07 |
| 2013-06-30 | 12.00% 10-Q · filed 2013-08-09 |
| 2013-03-31 | 12.00% 10-Q · filed 2013-05-09 |
| 2011-12-31 | 3.25% 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |